Trio Medicines LTD

Trio Medicines Ltd (Trio) is a small pharmaceutical company founded in 2005, wholly owned by Hammersmith Medicines Research Ltd (HMR), a CRO. Here, we focus on developing treatments for rare and unmet medical needs with the aim of improving the health and quality of life of patients around the world. Here at Trio, we are currently focused on producing effective treatments through the targeting of G-Protein Coupled Receptors (GPCRs) for a wide range of conditions. Our therapeutic expertise spans inflammatory, respiratory and cardiovascular conditions, as well as gastric neuroendocrine tumours (an orphan disease).

Website

http://www.triomedicines.com/

External link for Trio Medicines LTD

Industry

Pharmaceutical Manufacturing

Company size

2-10 employees

Headquarters

London

Type

Privately Held

Founded

2005

Specialties

Pharmaceuticals, G-Protein Coupled Receptors, Inflammatory Diseases, Respiratory Diseases, Cardiovascular Diseases, and Orphan Diseases